JP2012180344A5 - - Google Patents

Download PDF

Info

Publication number
JP2012180344A5
JP2012180344A5 JP2012023811A JP2012023811A JP2012180344A5 JP 2012180344 A5 JP2012180344 A5 JP 2012180344A5 JP 2012023811 A JP2012023811 A JP 2012023811A JP 2012023811 A JP2012023811 A JP 2012023811A JP 2012180344 A5 JP2012180344 A5 JP 2012180344A5
Authority
JP
Japan
Prior art keywords
alkyl
membered
haloalkyl
membered heterocyclyl
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012023811A
Other languages
English (en)
Japanese (ja)
Other versions
JP5620417B2 (ja
JP2012180344A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2012023811A priority Critical patent/JP5620417B2/ja
Priority claimed from JP2012023811A external-priority patent/JP5620417B2/ja
Publication of JP2012180344A publication Critical patent/JP2012180344A/ja
Publication of JP2012180344A5 publication Critical patent/JP2012180344A5/ja
Application granted granted Critical
Publication of JP5620417B2 publication Critical patent/JP5620417B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012023811A 2011-02-07 2012-02-07 アミノピラゾール誘導体を含む医薬 Active JP5620417B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2012023811A JP5620417B2 (ja) 2011-02-07 2012-02-07 アミノピラゾール誘導体を含む医薬

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2011024078 2011-02-07
JP2011024078 2011-02-07
JP2012023811A JP5620417B2 (ja) 2011-02-07 2012-02-07 アミノピラゾール誘導体を含む医薬

Publications (3)

Publication Number Publication Date
JP2012180344A JP2012180344A (ja) 2012-09-20
JP2012180344A5 true JP2012180344A5 (es) 2014-10-02
JP5620417B2 JP5620417B2 (ja) 2014-11-05

Family

ID=47011846

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012023811A Active JP5620417B2 (ja) 2011-02-07 2012-02-07 アミノピラゾール誘導体を含む医薬

Country Status (1)

Country Link
JP (1) JP5620417B2 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2902489B9 (en) * 2012-09-27 2018-02-07 Chugai Seiyaku Kabushiki Kaisha Fgfr3 fusion gene and pharmaceutical drug targeting same
CN103224479B (zh) * 2013-04-26 2014-10-15 温州大学 一种2-芳基苯并呋喃类化合物的合成方法
AU2014297298B2 (en) * 2013-07-31 2019-10-17 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical preparation comprising aminopyrazole derivative
EA028819B1 (ru) * 2013-10-25 2018-01-31 Новартис Аг Производные бициклического пиридила с конденсированными кольцами в качестве ингибиторов fgfr4
KR101768402B1 (ko) 2013-12-13 2017-08-14 에프. 호프만-라 로슈 아게 브루톤 티로신 키나제의 억제제
US9802920B2 (en) 2013-12-13 2017-10-31 Hoffman-La Roche Inc. Inhibitors of bruton's tyrosine kinase
WO2015099127A1 (ja) * 2013-12-27 2015-07-02 中外製薬株式会社 Ｆｇｆｒゲートキーパー変異遺伝子およびそれを標的とする医薬
DK3125936T3 (da) * 2014-03-31 2019-08-05 Debiopharm Int Sa Fgfr-fusioner
EP3200786B1 (en) * 2014-10-03 2019-08-28 Novartis AG Use of ring-fused bicyclic pyridyl derivatives as fgfr4 inhibitors
US9802917B2 (en) * 2015-03-25 2017-10-31 Novartis Ag Particles of N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((4-methyl-2-oxopiperazin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide
EP3312172B1 (en) * 2015-06-17 2020-05-06 Chugai Seiyaku Kabushiki Kaisha Aminopyrazole derivatives useful as src kinase inhibitors
WO2017028816A1 (zh) * 2015-08-20 2017-02-23 浙江海正药业股份有限公司 吲哚类衍生物及其制备方法和其在医药上的用途
CN110950848B (zh) * 2018-09-27 2024-03-26 徐诺药业 新型氨基吡唑类衍生物的合成与应用
CN112358435B (zh) * 2019-10-12 2023-01-10 中国医学科学院医药生物技术研究所 取代芳并杂环类化合物、制备方法和抑制ulk1及抗肿瘤用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1147476C (zh) * 1998-05-05 2004-04-28 霍夫曼-拉罗奇有限公司 作为p-38map激酶抑制剂的吡唑衍生物
US6316466B1 (en) * 1998-05-05 2001-11-13 Syntex (U.S.A.) Llc Pyrazole derivatives P-38 MAP kinase inhibitors
JP4838121B2 (ja) * 2003-06-26 2011-12-14 ノバルティス アーゲー ５員ヘテロ環を基礎とするｐ３８キナーゼ阻害剤
EP2307372B1 (en) * 2008-07-23 2012-04-25 F. Hoffmann-La Roche AG Heterocyclic antiviral compounds

Similar Documents

Publication Publication Date Title
JP2012180344A5 (es)
IL261852A (en) Imidazole-based converted compounds for the treatment of cancer
DK2900269T3 (en) COMBINATION OF REGORAFENIB AND ACETYLSALICYLIC ACID FOR TREATMENT OF COLORECTAL CANCER.
JP2018520195A5 (es)
JP2019537570A5 (es)
JP2013535491A5 (es)
PH12018550049A1 (en) Protein kinase inhibitor, preparation method and medical use thereof
JP2013510124A5 (es)
JP2014509659A5 (es)
RU2013106754A (ru) Производное фталазинонкетона, способ его получения и его фармацевтическое применение
JP2014512356A5 (es)
JP2013520443A5 (es)
JP2013507425A5 (es)
JP2014534200A5 (es)
RU2013128448A (ru) Производные триазола в качестве ингибиторов сигнального пути wnt
JP2014513704A5 (es)
JP2014512354A5 (es)
JP2012153722A5 (es)
JP2013510120A5 (es)
JP2013512903A5 (es)
RU2016130932A (ru) Производные хинолона как ингибиторы рецептора фактора роста фибробластов
RU2012112050A (ru) Производные дигидроптеридинона, способ их получения и фармацевтическое применение
RU2016122731A (ru) Функционализированные и замещенные индолы в качестве противораковых агентов
RU2016147654A (ru) Соединения для лечения рака
JP2019522055A5 (es)